Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Germany / NCT05811780
Recruiting Observational

The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry

NCT05811780 · tracked via the Priya Life Science Germany tracker
Sponsor
University Hospital Freiburg
Phase
Observational
Started
2014-04-29
Last updated
2023-04-13

Condition(s) studied

Medical Condition Requiring Extracorporeal Organ Support

Study summary

A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Treatment with any kind of extracorporeal organ support Exclusion Criteria: * none

Primary outcome measure(s)

  • Hospital survival — 30 days
    Survival of index hospitalization (yes/no)

Trial sites (1)

FacilityCityRegionStatus
University of Freiburg Medical Center Freiburg im Breisgau Germany Recruiting

More University Hospital Freiburg trials in Germany

Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project Recruiting
Incidence of Colon Ischemia in Patients After Cardiopulmonary Resuscitation (CPR) Starting soon
Video Capsule Endoscopy for Detection of Gastrointestinal Bleeding in the Small Bowel Recruiting
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood Recruiting
Pathogen-microbiome Interaction During Helicobacter Pylori Infection Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05811780 on ClinicalTrials.gov ↗ ← All trials in Germany